Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
BACKGROUND: Despite the proven benefits of aspirin therapy in the primary and secondary prevention of cardiovascular disease (CVD), utilization rates of aspirin remain suboptimal in relation to recommendations. We studied national trends of aspirin use among intermediate- to high-risk patients in th...
Format: | Article |
---|---|
Language: | English |
Published: |
Public Library of Science (PLoS)
2005-12-01
|
Series: | PLoS Medicine |
Online Access: | http://dx.doi.org/10.1371/journal.pmed.0020353 |
Similar Items
-
Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
by: Randall S Stafford, et al.
Published: (2005-12-01) -
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
by: Fernández-de-Bobadilla Jaime, et al.
Published: (2007-10-01) -
US population qualifying for aspirin use for primary prevention of cardiovascular disease
by: Athena L. Huang, et al.
Published: (2024-06-01) -
US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
by: Athena L. Huang, MD, et al.
Published: (2023-09-01) -
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
by: Hennekens, C, et al.
Published: (1989)